{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T05:23:48Z","timestamp":1772774628780,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rbmojournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.rbmo.2018.12.030","type":"journal-article","created":{"date-parts":[[2018,12,24]],"date-time":"2018-12-24T20:20:32Z","timestamp":1545682832000},"page":"1010-1017","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Pituitary suppression protocol among Bologna poor responders undergoing ovarian stimulation using corifollitropin alfa: does it play any role?"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2038-2571","authenticated-orcid":false,"given":"Joaquin","family":"Err\u00e1zuriz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiotis","family":"Drakopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7221-4361","authenticated-orcid":false,"given":"David","family":"Pening","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Racca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Romito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6404-2638","authenticated-orcid":false,"given":"Nelke","family":"De Munck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herman","family":"Tournaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"De Vos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Blockeel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rbmo.2018.12.030_bib0001","first-page":"526","article-title":"Gonadotrophin-releasing hormone antagonists for assisted reproductive technology","volume":"15","author":"Al-Inany","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.rbmo.2018.12.030_bib0002","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.fertnstert.2016.02.005","article-title":"A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept","volume":"105","author":"Alviggi","year":"2016","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2018.12.030_bib0003","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.fertnstert.2015.04.018","volume":"104","author":"Boostanfar","year":"2015","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2018.12.030_bib0004","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/humrep\/deh668","article-title":"GnRH antagonist versus long GnRH agonist protocol in poor responders undergoing IVF: a randomized controlled trial","volume":"20","author":"Cheung","year":"2005","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2018.12.030_bib0005","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.fertnstert.2005.07.1280","article-title":"Gonadotrophin-releasing hormone (GnRH) antagonist plus recombinant luteinizing hormone versus a standard GnRH agonist short protocol in patients at risk for poor ovarian response","volume":"85","author":"De Placido","year":"2006","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2018.12.030_bib0006","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1093\/humrep\/dep291","article-title":"A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol","volume":"24","author":"Devroey","year":"2009","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2018.12.030_bib0007","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1210\/jc.2003-031766","article-title":"Induction of Multiple Follicular Development by a Single Dose of Long-Acting Recombinant Follicle-Stimulating Hormone (FSH-CTP, Corifollitropin Alfa) for Controlled Ovarian Stimulation beforein vitro Fertilization","volume":"89","author":"Devroey","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.rbmo.2018.12.030_bib0008","article-title":"Conventional ovarian stimulation and single embryo transfer for IVF\/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?","volume":"316","author":"Drakopoulos","year":"2016","journal-title":"Hum. Reprod. dev"},{"key":"10.1016\/j.rbmo.2018.12.030_bib0009","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1093\/humrep\/dex296","article-title":"Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial","volume":"32","author":"Drakopoulos","year":"2017","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2018.12.030_bib0010","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.rbmo.2010.06.032","article-title":"Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF","volume":"21","author":"Fauser","year":"2010","journal-title":"Reprod. BioMed. Online"},{"key":"10.1016\/j.rbmo.2018.12.030_bib0011","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/humrep\/der092","article-title":"ESHRE consensus on the definition of \u2018poor response\u2019 to ovarian stimulation forin vitro fertilization: the Bologna criteria","volume":"26","author":"Ferraretti","year":"2011","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2018.12.030_bib0012","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.fertnstert.2011.09.051","article-title":"Poor responders: still a problem","volume":"96","author":"Frydman","year":"2011","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2018.12.030_bib0013","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S1472-6483(10)60652-9","article-title":"GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis","volume":"13","author":"Griesinger","year":"2006","journal-title":"Reprod. BioMed. Online"},{"key":"10.1016\/j.rbmo.2018.12.030_bib0015","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1186\/s12958-018-0342-1","article-title":"Individualized controlled ovarian stimulation in expected poor-responders: an update","volume":"16","author":"Haahr","year":"2018","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.rbmo.2018.12.030_bib0016","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s11596-013-1134-7","article-title":"Cumulative live birth rate after three ovarian stimulation IVF cycles for poor ovarian responders according to the bologna criteria","volume":"33","author":"Ke","year":"2013","journal-title":"J. Huazhong Univ. Sci. Technol. [Med. Sci.]"},{"key":"10.1016\/j.rbmo.2018.12.030_bib0017","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/humrep\/deu301","article-title":"Corifollitropin alfa compared with follitropin beta in poor responders undergoing ICSI: a randomized controlled trial","volume":"30","author":"Kolibianakis","year":"2015","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2018.12.030_bib0018","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/humrep\/den107","article-title":"Flexible GnRH antagonist versus flare-up GnRH agonist protocol in poor responders treated by IVF: a randomized controlled trial","volume":"23","author":"Lainas","year":"2008","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2018.12.030_bib0019","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/humupd\/dmx017","article-title":"GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type","volume":"23","author":"Lambalk","year":"2017","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.rbmo.2018.12.030_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/humupd\/dmr037","article-title":"The poor responder in IVF: is the prognosis always poor? A systematic review","volume":"18","author":"Oudendijk","year":"2011","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.rbmo.2018.12.030_bib0021","series-title":"Interventions for and apos;poor responders and apos; to controlled ovarian hyper stimulation (COH) inin vitro fertilization (IVF), Cochrane Database of Systematic Reviews","author":"Pandian","year":"2010"},{"key":"10.1016\/j.rbmo.2018.12.030_bib0022","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.fertnstert.2018.01.002","article-title":"The use of preimplantation genetic testing for aneuploidy (PGT-A): a committee opinion","volume":"109","author":"Penzias","year":"2018","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2018.12.030_bib0023","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1093\/humrep\/des318","article-title":"Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria","volume":"27","author":"Polyzos","year":"2012","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2018.12.030_bib0024","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3109\/09513590.2015.1065481","article-title":"Corifollitropin alfa followed by hpHMG in GnRH agonist protocols. Two prospective feasibility studies in poor ovarian responders","volume":"31","author":"Polyzos","year":"2015","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.rbmo.2018.12.030_bib0025","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1093\/humrep\/det045","article-title":"Addition of highly purified HMG after corifollitropin alfa in antagonist-treated poor ovarian responders: a pilot study","volume":"28","author":"Polyzos","year":"2013","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2018.12.030_bib0026","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.fertnstert.2012.09.043","article-title":"Corifollitropin alfa followed by rFSH in a GnRH antagonist protocol for poor ovarian responder patients: an observational pilot study","volume":"99","author":"Polyzos","year":"2013","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2018.12.030_bib0027","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.fertnstert.2012.09.043","article-title":"Corifollitropin alfa followed by rFSH in a GnRH antagonist protocol for poor ovarian responder patients: an observational pilot study","volume":"99","author":"Polyzos","year":"2013","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2018.12.030_bib0028","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.fertnstert.2011.09.048","article-title":"A systematic review of randomized trials for the treatment of poor ovarian responders: is there any light at the end of the tunnel?","volume":"96","author":"Polyzos","year":"2011","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2018.12.030_bib0029","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.rbmo.2013.11.010","article-title":"Live birth rates in Bologna poor responders treated with ovarian stimulation for IVF\/ICSI","volume":"28","author":"Polyzos","year":"2014","journal-title":"Reprod. BioMed. Online"},{"key":"10.1016\/j.rbmo.2018.12.030_bib0030","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/humrep\/det426","article-title":"Poor ovarian responders: to meta-analyse or not, that is the question","volume":"29","author":"Polyzos","year":"2014","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2018.12.030_bib0031","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1093\/humrep\/der240","article-title":"Comparisons of GnRH antagonist versus GnRH agonist protocol in poor ovarian responders undergoing IVF","volume":"26","author":"Pu","year":"2011","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2018.12.030_bib0032","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1472-6483(10)60957-1","article-title":"GnRH antagonist in IVF poor-responder patients: results of a randomized trial","volume":"11","author":"Roberto","year":"2005","journal-title":"Reprod. BioMed. Online"},{"key":"10.1016\/j.rbmo.2018.12.030_bib0033","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.fertnstert.2013.09.035","article-title":"Long gonadotrophin-releasing hormone agonist versus short agonist versus antagonist regimens in poor responders undergoingin vitro fertilization: a randomized controlled trial","volume":"101","author":"Sunkara","year":"2014","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2018.12.030_bib0034","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/352098","article-title":"Management of Poor Responders in IVF: Is There Anything New?","volume":"2014","author":"Ubaldi","year":"2014","journal-title":"BioMed Research International"},{"key":"10.1016\/j.rbmo.2018.12.030_bib0035","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.fertnstert.2004.08.029","article-title":"Intracytoplasmic sperm injection as a treatment for unexplained total fertilization failure or low fertilization after conventionalin vitro fertilization","volume":"83","author":"Van der Westerlaken","year":"2005","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2018.12.030_bib0036","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.fertnstert.2004.10.054","article-title":"Blastocyst formation inin vitro fertilization versus intracytoplasmic sperm injection cycles: Influence of the fertilization procedure","volume":"83","author":"Van Landuyt","year":"2005","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2018.12.030_bib0037","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1472-6483(10)61022-X","article-title":"New Belgian embryo transfer policy leads to sharp decrease in multiple pregnancy rate","volume":"13","author":"Van Landuyt","year":"2006","journal-title":"Reprod. BioMed. Online"},{"key":"10.1016\/j.rbmo.2018.12.030_bib0038","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1093\/humrep\/des118","article-title":"The Bologna criteria for poor ovarian response; has the job been accomplished?","volume":"27","author":"Younis","year":"2012","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2018.12.030_bib0039","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.rbmo.2017.09.017","article-title":"Finding a place for corifollitropin within the PIVET FSH dosing algorithms","volume":"36","author":"Yovich","year":"2018","journal-title":"Reprod. BioMed. Online"},{"key":"10.1016\/j.rbmo.2018.12.030_bib0040","doi-asserted-by":"crossref","DOI":"10.4172\/2375-4508.1000165","article-title":"Cumulative Live Birth Rate: An Outmoded Term","volume":"04","author":"Yovich","year":"2016","journal-title":"JFIV Reprod. Med. Genet."},{"key":"10.1016\/j.rbmo.2018.12.030_bib0041","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1093\/humrep\/dex234","article-title":"The International Glossary on Infertility and Fertility Care, 2017\u2020\u2021\u00a7","volume":"32","author":"Zegers-Hochschild","year":"2017","journal-title":"Hum. Reprod."}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147264831830659X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147264831830659X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:15:41Z","timestamp":1761466541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147264831830659X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S147264831830659X"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2018.12.030","relation":{},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pituitary suppression protocol among Bologna poor responders undergoing ovarian stimulation using corifollitropin alfa: does it play any role?","name":"articletitle","label":"Article Title"},{"value":"Reproductive BioMedicine Online","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbmo.2018.12.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}